Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on D Lysine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102206185A reveals a dual-solvent recrystallization method achieving >99.6% purity and <0.2% impurities for cataract drug intermediates.
Patent CN106191151B reveals a novel biotransformation route for high-purity D-lysine and 5-aminovaleric acid co-production, offering significant supply chain and cost advantages for global manufacturers.
Novel patent CN109824547A enables safer synthesis of double protected amino acids. Achieve high purity and reduced costs for pharmaceutical intermediate manufacturing supply chains.